The clinical description of newly reported BBSOAS patients, in combination with experimental research in vitro and in vivo, will ultimately allow for a better comprehension of this recently described syndrome and the roles played by NR2F1 during early development. This evidence concerns the gene NR2F1 and Bosch-Boonstra-Schaaf optic atrophy syndrome.